Captor Therapeutics S.A. (CTX)
Market Closed
10 Aug, 14:50
WSE 
zł
69. 90
-0.1
-0.1429%
zł
- Market Cap
- P/E Ratio
- Div Yield
6,010 Volume
- Eps
zł 70
Previous Close Want to track CTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Captor Therapeutics S.A. (CTX) Statistics
Valuation metrics
Market Cap -
Enterprise value 444.18M
Trailing P/E (ttm) -9.07
Forward P/E -
PEG ratio -5.74
Price/Sales (ttm) 186.12
Price/Book (mrq) 32.22
Enterprise Value/Revenue 186.47
Enterprise Value/EBITDA -10.92
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 6.06K
Average volume (90 days) 3.35K
Price summary
52-Week low 33
52-Week high 89.2
Beta -
50-Day moving average 74.77
200-Day moving average 78.45
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -17.91%
Operating margin -19.74%
Operational effectiveness
Return on assets -1.63%
Return on equity -1.5%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.43
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -7.69
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.22
Total debt (mrq) -
Total Debt/Equity (mrq) 0.26
Current ratio (mrq) 1.6%
Book value per share (mrq) 2.17
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
